Brief: Biosenic Reaches Agreement With Global Tech Opportunities 15 To Finalise Bonds Programme
18/10/2023 06:10
Oct 18 (Reuters) - Bone Therapeutics SA BIOS.BR :
* TO DRAW FINAL TRANCHES OF ITS PRESENT GLOBAL TECH
OPPORTUNITIES
15 CONVERTIBLE BONDS PROGRAM AND SECURE RUNWAY END OF JANUARY
2024
* ANNOUNCES THAT IT HAS REACHED A DEFINITIVE AGREEMENT WITH
GLOBAL
TECH OPPORTUNITIES 15 (GTO15) WITH RESPECT TO FINALIZATION OF
EXISTING CONVERTIBLE BONDS PROGRAM
* ANTICIPATES HAVING SUFFICIENT CASH TO CARRY OUT ITS
BUSINESS
OBJECTIVES UNTIL END OF JANUARY 2024
Source text for Eikon: ID:nGNE8QmPDh
Further company coverage: BIOS.BR
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Biosenic SA
See all newsBrief: Biosenic Says Enterprise Court Of Nivelles Approves Co's Restructuring Plan
Brief: Biosenic Anticipates Having Sufficient Cash To Carry Out Its Business Objectives Until Q3 2024
Brief: BioSenic Patent Granted In Canada For Broader Protection Of ATO Therapeutic Platform
Brief: Biosenic Files For Additional Patent Protection For Osteoarthritis Drug
Brief: BioSenic Signs New Binding Term Sheet With Phebra PTY Ltd